Total medical devices industry cross border M&A deals worth $2.2bn were announced in Europe in Q2 2022, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 1312.3% over the previous quarter and a rise of 16.1% when compared with the last four-quarter average of $1.86bn.

Europe held an 80.30% share of the global medical devices industry cross border M&A deal value that totalled $2.69bn in Q2 2022. With a 66.17% share and deals worth $1.78bn, Germany was the top country in Europe’s cross border M&A deal value across medical devices industry.

In terms of deal activity, Europe recorded 36 cross border deals during Q2 2022, marking a decrease of 21.74% over the previous quarter and a rise of 17.07% over the last four-quarter average. Germany recorded nine deals during the quarter.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Europe medical devices industry cross border M&A deals in Q2 2022: Top deals

The top five medical devices industry cross border M&A deals accounted for 89.9% of the overall value during Q2 2022.

The combined value of the top five cross border M&A deals stood at $1.94bn, against the overall value of $2.2bn recorded for the quarter.

The top five medical devices industry cross border deals of Q2 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $541.63m acquisition of Phenox by Wallaby Medical

3) Integer $141.73m acquisition deal with Aran Biomedical

4) The $138.06m acquisition of SunshineSmile by Straumann

5) Cochlear $122.03m acquisition deal with Oticon Medical